Amikacin and cefoperazone/sulbactam alone or in combination against carbapenem-resistant Pseudomonas aeruginosa

AMK-SCF combination did not show better bactericidal effect on AMK-sensitive CRPA-caused infections compared with AMK alone. Although further studies are needed, these results suggest that this combination does not seem to be indicated for treatment of CRPA-caused infections.